(Q45868039)

English

Prophylactic treatment with activated prothrombin complex concentrate (FEIBA) reduces the frequency of bleeding episodes in paediatric patients with haemophilia A and inhibitors

scientific article published in May 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/17498073

Prophylactic treatment with activated prothrombin complex concentrate (FEIBA) reduces the frequency of bleeding episodes in paediatric patients with haemophilia A and inhibitors (English)

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/17498073

0 references

0 references

prothrombin complex concentrate

1 reference

based on heuristic

inferred from title

author name string

Leissinger CA

1

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/17498073

Becton DL

2

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/17498073

Ewing NP

3

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/17498073

Valentino LA

4

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/17498073

publication date

1 May 2007

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/17498073

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/17498073

13

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/17498073

3

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/17498073

249-255

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/17498073

The target joint

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01442.X

21 January 2018

Factor VIII inhibitors in mild and moderate-severity haemophilia A.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01442.X

21 January 2018

Literature review of surgery management in inhibitor patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01442.X

21 January 2018

Use of prothrombin complex concentrates and activated prothrombin complex concentrates as prophylactic therapy in haemophilia patients with inhibitors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01442.X

21 January 2018

Use of activated prothrombin complex concentrate over multiple surgical episodes in a hemophilic child with an inhibitor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01442.X

21 January 2018

Activated prothrombin complex concentrate (FEIBA) treatment during surgery in patients with inhibitors to FVIII/IX.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01442.X

21 January 2018

Activated prothrombin complex concentrate (FEIBA) treatment during surgery in patients with inhibitors to FVIII/IX: the updated Norwegian experience

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01442.X

21 January 2018

Evidence for the use of activated prothrombin complex concentrates (aPCCs) in the treatment of patients with haemophilia and inhibitors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01442.X

21 January 2018

Long‐term FEIBA prophylaxis does not prevent progression of existing joint disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01442.X

21 January 2018

German recommendations for immune tolerance therapy in type A haemophiliacs with antibodies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01442.X

21 January 2018

Current treatment of hemophilic arthropathy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01442.X

21 January 2018

Orthopaedic outcome of total knee replacement in haemophilia A.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01442.X

21 January 2018

Radiological and orthopedic score in pediatric hemophilic patients with early and late prophylaxis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01442.X

21 January 2018

When should prophylactic treatment in patients with haemophilia A and B start?--The German experience

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01442.X

21 January 2018

Quality-of-life differences between prophylactic and on-demand factor replacement therapy in European haemophilia patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01442.X

21 January 2018

Complications associated with the treatment of haemophiliacs with inhibitors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01442.X

21 January 2018

Prevention of bleeds in hemophilia patients with inhibitors: emerging data and clinical direction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01442.X

21 January 2018

Safety of factor VIII inhibitor bypass activity (FEIBA): 10-year compilation of thrombotic adverse events

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01442.X

21 January 2018

FEIBA safety profile in multiple modes of clinical and home-therapy application

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01442.X

21 January 2018

Identifiers

10.1111/J.1365-2516.2007.01442.X

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/17498073

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/17498073

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45868039&oldid=2087678061"